


【白云山:药品阿莫西林颗粒通过仿制药一致性评价】财联社3月15日电,白云山公告,分公司白云山制药总厂药品阿莫西林颗粒通过仿制药一致性评价。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”